¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lipoprotein electrophoresis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® electrophoresis ÇÑ±Û Àü±âÀ̵¿
¼³¸í   
  Àü±â¿îµ¿Àû Çö»óÀÇ Çϳª·Î¼­ ÀüÀå¿¡¼­ ¾ç±ØÀ̳ª À½±ØÀ¸·Î ÇâÇϴ ÀÔÀÚÀÇ ¿îµ¿À» ÀÌ¿ëÇÏ¿© ¹°ÁúÀÇ ºÐ¼®À̳ª Á¤·®¿¡ ÀÌ¿ëÇϴ ¹æ¹ý. ¿ë¾× ¼Ó¿¡¼­ Àü±Ø¿¡ Àü¾ÐÀ» °¡Çϸ頱נÀÔÀÚ°¡ À½¼º Àü±â¸¦ ¶ì°í ÀÖÀ¸¸é ¾ç±ØÀ¸·Î, ±×¸®°í ¾ç¼º Àü±â¸¦ ¶ì°í ÀÖÀ¸¸é À½±ØÀ¸·Î Àü±âÀÇ ÈûÀ» ¹Þ¾Æ¼­ À̵¿ÀÌ µÈ´Ù. À̵¿Çϴ ¸ð¾çµµ ÀÔÀÚÀÇ Çüųª Å©±â¿¡ µû¶ó ´Ù¸£¹Ç·Î ´Ü¹éÁúÀÇ ºÐ¼®¿¡ ÀÌ¿ëµÉ ¼ö°¡ ÀÖ´Ù. À̵¿¼Óµµ´Â ÀÔÀÚÀÚüÀÇ ÀüÇÏ ¹× Å©±â, ºÐÀÚ±¸Á¶¸¦ ºñ·ÔÇÏ¿© ¿ë¸ÅÀÇ Á¾·ù, ÁöÁöü ¹°Áú°úÀÇ »óÈ£ÀÛ¿ë, ¿Âµµ µî¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ°Ô µÈ´Ù. Àü±âÀ̵¿Àº À̵¿µµÀÇ Â÷ÀÌ¿¡ ÀÇÇØ¼­ ¹°ÁúÀÇ ºÐ¸®, Á¤Á¦, È®ÀÎ, ¼øµµÀÇ °ËÁ¤ µîÀ» ½ÃÇàÇϴ °ÍÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹éÁú
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹éÁú
  • lipoprotein
    ÁöÁú´Ü¹éÁú
  • lipoprotein lipase
    ÁöÁú´Ü¹éÁöÁúºÐÇØÈ¿¼Ò
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹éÁú
  • pre-beta-lipoprotein
    ÇÁ¸®º£Å¸ÁöÁú´Ü¹éÁú
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹éÁú
  • agarose gel electrophoresis
    ¿ì¹«°ÖÀü±âÀ̵¿
  • capillary electrophoresis
    ¸ð¼¼°üÀü±âÀ̵¿
  • disc electrophoresis
    ¿ø¹ÝÀü±âÀ̵¿
  • electrophoresis
    Àü±âÀ̵¿, Àü±â¿µµ¿
  • hemoglobin electrophoresis
    Ç÷»ö¼ÒÀü±âÀ̵¿, Çì¸ð±Û·ÎºóÀü±âÀ̵¿
  • isoelectric electrophoresis
    µîÀüÀü±âÀ̵¿
  • moving boundary electrophoresis
    À̵¿°æ°èÀü±âÀ̵¿
  • pulsed-field gel electrophoresis
    °£Ç濵¿ª°ÖÀü±âÀ̵¿
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • electrophoresis
    Àü±âÀ̵¿, Àü±â¿µµ¿
  • hemoglobin electrophoresis
    Ç÷»ö¼ÒÀü±âÀ̵¿, Ç÷»ö¼ÒÀü±â¿µµ¿
  • lipoprotein
    ÁöÁú´Ü¹é
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹é
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high-density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹é
  • lipoprotein
    ÁöÁú´Ü¹é
  • agarose gel electrophoresis
    ¿ì¹«°ÖÀü±âÀ̵¿
  • capillary electrophoresis
    ¸ð¼¼°üÀü±âÀ̵¿
  • disc electrophoresis
    ¿ø¹ÝÀü±âÀ̵¿
  • electrophoresis
    Àü±âÀ̵¿, Àü±â¿µµ¿
  • immune electrophoresis
    ¸é¿ªÀü±âÀ̵¿¹ý
  • isoelectric electrophoresis
    µîÀü¾ÐÀü±âÀ̵¿
  • moving boundary electrophoresis
    À̵¿°æ°èÀü±âÀ̵¿
  • pulsed-field gel electrophoresis
    °£Ç濵¿ª°ÖÀü±âÀ̵¿
  • starch gel electrophoresis
    ³ì¸»°ÖÀü±âÀ̵¿
  • zone electrophoresis
    ±¸¿ªÀü±âÀ̵¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agarose gel electrophoresis
    ÇÑõ°ÖÀü±â¿­µ¿
  • agarose gel electrophoresis
    ¾Æ°¡·Î½º°ÖÀü±â¿µµ¿¹ý
  • immune electrophoresis
    ¸é¿ªÀü±â¿µµ¿¹ý.
  • pulsed-field gel electrophoresis (PFGE)
    °£Çæ¾ß Àü±â¿µµ¿
  • High-density lipoprotein = HDL
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • IDL = intermediate density lipoprotein
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate density lipoprotein =IDL
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • LDL = low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é(î¸ÚËÓøò·Ó±ÛÜ)
  • Lipoprotein
    Áö´Ü¹é(ò·Ó±ÛÜ)
  • Lipoprotein lipase
    Áö´Ü¹é(ò·Ó±ÛÜ) Áö¹æºÐÇØÈ¿¼Ò(ò·Û¸ÝÂú°ý£áÈ)
  • Lp(a) lipoprotein
    Lp(a) Áö´Ü¹é
  • LpX lipoprotein
    LpX Áö´Ü¹é
  • VLDL => very low density lipoprotein
    ÃÊÀú¹ÐµµÁö ´Ü¹éÁú
  • high-density lipoprotein
    °í¹ÐµµÁö¹æ´Ü¹é
  • plasma lipoprotein abnormalities
    Ç÷ÀåÁöÁú´Ü¹éÁúÀÌ»óÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta-lipoprotein
    º£Å¸-Áö´Ü¹é<--ÁöÁú´Ü¹éÁú>
  • dyslipoproteinemia lipoprotein
    ÀÌ»óÁö¹æ´Ú¹éÇ÷Á¾ Áö¹æ´Ü¹é
  • familial high density lipoprotein def
    °¡Á·¼º °íºñÁ߸®Æ÷´Ü¹éÁú°áÇÌ Áõ.
  • high-density lipoprotein
    °í¹ÐµµÁö¹æ´Ü¹é
  • intermediate density lipoprotein =IDL ´ç´¢
    Áß°£ºñÁßÁö(Áú)´Ü¹é(Áú).
  • lipid/lipoprotein
    ÁöÁú/Áö´Ü¹é
  • lipid/lipoprotein level
    ÁöÁú/Áö´Ü¹é Ä¡(°ª)
  • lipoprotein
    ÁöÁú´Ü¹é(¡­Ó±ÛÜ)
  • lipoprotein X
    Áö´Ü¹é X
  • lipoprotein deficiency
    Áö´Ü¹é°áÇÌ
  • lipoprotein lipase
  • lipoprotein lipase deficiency
    Áö´Ü¹é¸®ÆÄÁ¦°áÇÌ(Áõ)
  • lipoprotein metabolism
    Áö´Ü¹é´ë»ç
  • lipoprotein,low-density
    Àú¹Ðµµ(î¸ÚËÓø)
  • lipoprotein,very-low-density
    ÃÊÀúºñÁß(õ±î¸Ýïñì)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta lipoprotein
    º£Å¸ ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • broad-beta lipoprotein
    ±¤´ë(ÎÆÓá) º£Å¸ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • floating beta lipoprotein
    ºÎÀ¯(Ý©ë´) º£Å¸ ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • high-density lipoprotein
    °í¹Ðµµ ÁöÁú´Ü¹éÁú(ÍÔÚËÓøò·òõÓ±ÛÜòõ)
  • high-lipid lipoprotein
    °íÁöÁú ÁöÁú´Ü¹éÁú(ÍÔò·òõò¢òõÓ±ÛÜòõ)
  • lipoprotein
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • lipoprotein lipase
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ) ¶óÀÌÆäÀ̽º
  • lipoprotein tissue factor
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ) Á¶Á÷ÀÎÀÚ(ðÚòÄì×í­)
  • low-density lipoprotein
    Àú¹Ðµµ Áö´Ü¹éÁú(î¸ÚËÓøò·Ó±ÛÜòõ)
  • low-lipid lipoprotein
    ÀúÁöÁú Áö´Ü¹éÁú(î¸ò·òõò·Ó±ÛÜòõ)
  • very high-density lipoprotein
    Ãʰí¹Ðµµ(õ±ÍÔÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very high-lipid lipoprotein
    ÃʰíÁöÁú(õ±ÍÔò·òõ) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very low-density lipoprotein
    ÃÊÀú¹Ðµµ (õ±î¸ÚËÓø) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very low-lipid lipoprotein
    ÃÊÀúÁöÁú(õ±î¸ò·òõ) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • electrophoresis
    Àü±â¿µµ¿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LEP lethal effective phase; lipoprotein electrophoresis; low egg passage; lower esophagus
LPE lipoprotein electrophoresis; lysophosphatidylethanolamine
UPEP urinary protein electrophoresis; urine protein electrophoresis
CIE Counter(current) Immuno-Electrophoresis; ¿ª¸é¿ª Àü±â ¿µµ¿¹ý
HDL High Density Lipoprotein; °í¹Ðµµ ÁöÁú ´Ü¹éÁú
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LDL-C lipoprotein cholesterol and low-density lipoprotein cholesterol
ACE Affinity capillary electrophoresis
AGE Agarose gel electrophoresis
BN-PAGE Blue Native polyacrylamide gel electrophoresis
CGE Capillary Gel Electrophoresis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • beta-lipoprotein
    º£Å¸ Áö¹æ ´Ü¹é
    Ç÷Áß ÁöÁú·Î Ư¼öÇÑ ¾ÆÆ÷ ´Ü¹éÀÌ °áÇÕµÈ °ÍÀ» ¸®Æ÷ ´Ü¹éÀ̶ó°í Çϴµ¥ ±× Áß¿¡¼­ Àü±â¿µµ¿¿¡ ÀÇÇØ¼­ º£Å¸ ±Û·ÎºÒ¸°ÀÇ ºÎÀ§¿¡ °ËÃâµÇ´Â °Í.
  • cellulose acetate electrophoresis
    ¼¿·ê·ÎÁî ¾Æ¼¼Å×ÀÌÆ® Àü±â ¿µµ¿¹ý
    ¼¼·ê·ÎÁî ¾Æ¼¼Å×ÀÌÆ®¸¦ ÁöÁöü·Î ÇÏ¿© »ç¿ëÇÑ ¸é¿ª Àü±â ¿µµ¿¹ý. ¼¼·ê·ÎÁî ¾Æ¼¼Å×ÀÌÆ® ¸·Àº °Ö, ÇÑõ µîÀÇ ÁöÁöü¿Í ºñ±³ÇÏ¿© 󸮰¡ ¿ëÀÌÇϱ⠶§¹®¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÁö¸¸, ÇÑÆí °ËüÃþÀÌ ÀûÀº °æ¿ì ¹°ÁúÀÇ Á¤Á¦ ÃßÃâ¿¡´Â ÀûÇÕÇÏÁö ¾Ê´Ù.
  • disc gel electrophoresis
    µð½ºÅ© °Ö Àü±â¿µµ¿¹ý
    Olstein°ú Davis¿¡ ÀÇÇÏ¿© â¾ÈµÈ ¹æ¹ý. Disc¶õ ¿µµ¿ÇÒ ¶§ ¿ÏÃæ¾×ÀÇ
  • dyslipoproteinemia lipoprotein
    ÀÌ»ó Áö¹æ ´Ü¹éÇ÷Á¾ Áö¹æ ´Ü¹é
  • electrophoresis apparatus
    Àü±â ¿µµ¿ ÀåÄ¡
  • high-density lipoprotein
    °í¹Ðµµ Áö¹æ ´Ü¹é
  • lipoprotein metabolism disorer
    Áö´Ü¹é ´ë»ç Àå¾Ö
  • low-density lipoprotein
    Àú¹Ðµµ Áö¹æ ´Ü¹é
  • paper electrophoresis apparatus
    ¿©Áö Àü±â ¿µµ¿ ÀåÄ¡
  • very low density lipoprotein
    ÃÊÀú ºñÁß Áö´Ü¹é, ÃÊÀú ºñÁß ÁöÁú ´Ü¹é, ÃÊÀú ºñÁß Áö´Ü¹éÁú, ÃÊÀú ºñÁß ÁöÁú ´Ü¹éÁú, ÃÊÀúºñÁß Áö¹æ ´Ü¹é
  • zonal electrophoresis
    ´ëÀü±â¿µµ¿, ´ëÀü±â¿µµ¿¹ý
  • zone electrophoresis
    ±¸¿ª Àü±â¿µµ¿¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
lipoprotein electrophoresis Electrophoretic separation of plasma lipoproteins.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
a1-lipoprotein A lipoprotein fraction of relatively low molecular weight, high density, rich in phospholipids, and found in the a1-globulin fraction of human plasma.
(05 Mar 2000)
b1-lipoprotein A lipoprotein fraction of relatively high molecular weight, low density, rich in cholesterol, and found in the beta-globulin fraction of human plasma.
(05 Mar 2000)
receptors, lipoprotein Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognise the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis.
(12 Dec 1998)
very low density lipoprotein <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats (particularly triglycerides) in the bloodstream.
Elevations in very low density lipoprotein in the bloodstream are associated with an increased risk of atherosclerosis and coronary artery disease.
Acronym: VLDL
(18 Nov 1997)
multiple lipoprotein-type hyperlipidaemia <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease.
Origin: Gr. Haima = blood
(27 Sep 1997)
high density lipoprotein <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream.
Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease).
Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women.
Acronym: HDL
(18 Nov 1997)
intermediate density lipoprotein Class of lipoproteins formed in degradation of very-low-density lipoproteins; about half are cleared quickly from the plasma into the liver by receptor-mediated endocytosis; the other half are degraded into low density lipoproteins.
(05 Mar 2000)
familial high density lipoprotein deficiency Familial high {density lipoprotein deficiency}; a heritable disorder of lipid metabolism characterised by almost complete absence from plasma of high density lipoproteins, and by storage of cholesterol esters in foam cells, tonsillar enlargement, an orange or yellow-gray colour of the pharyngeal and rectal mucosa, hepatosplenomegaly, lymph node enlargement, corneal opacity, and peripheral neuropathy; autosomal recessive inheritance.
Synonym: familial high {density lipoprotein deficiency}, Tangier disease.
Origin: G. An-, priv., + alpha, a, + lipoprotein + -aemia, blood
(05 Mar 2000)
familial lipoprotein lipase deficiency An rare inherited disorder where there is a deficiency of an enzyme (lipoprotein lipase) which breaks down fat molecules, causing the accumulation of fats or lipoproteins in the blood.
Symptoms in infancy include abdominal pain (appears as if its colic), failure to thrive and skin lesions (xanthomas).
(27 Sep 1997)
familial lipoprotein lipase inhibitor An inhibitor found in certain individuals that inhibits lipoprotein lipase resulting in accumulation of chylomicrons, VLDL, and triacylglycerols; similar in symptoms to familial lipoprotein lipase deficiency.
(05 Mar 2000)
lipoprotein <biochemistry> An important class of serum proteins in which a spherical hydrophobic core of triglycerides or cholesterol esters surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins.
Classified according to density: chylomicrons, large low density particles, very low density, low density and high density species.
Important in lipid transport, especially cholesterol transport in the blood stream. Abnormalities in lipoprotein metabolism have been implicated in certain heart diseases.
(13 Nov 1997)
lipoprotein(a) A family of lipoprotein particles varying in density and size depending on the protein-lipid ratio and the protein composition. These particles consist of apolipoprotein b-100 covalently linked to apolipoprotein-a by one or two disulfide bonds. There is a correlation between high plasma levels of this lipoprotein and increased risk for atherosclerotic cardiovascular disease.
(12 Dec 1998)
lipoprotein(a) hyperlipoproteinaemia Elevated levels of lipoprotein(a) in the serum; associated with an increased risk of coronary disease.
(05 Mar 2000)
lipoprotein-associated coagulation inhibitor Formerly known as anticonvertin; a protein that inhibits the extrinsic pathway of coagulation by binding to the tissue factor III-factor VII-Calcium-factor Xa complex.
(05 Mar 2000)
lipoprotein lipase <enzyme> An enzyme of the hydrolase class that catalyses the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinaemia type I.
Chemical name: Triacylglycero-protein acylhydrolase
Registry number: EC 3.1.1.34
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • electrophoresis
    Àü±âÀ̵¿;Àü±â¿µµ¿¹ý
  • lipoprotein
    Áö´Ü¹éÁú;¸®Æ÷ ´Ü¹éÁú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á